Original Query: ALL
Previous Study | Return to List | Next Study

An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00373659
Recruitment Status : Completed
First Posted : September 8, 2006
Last Update Posted : June 13, 2012
Information provided by (Responsible Party):
Philip J. Rosenfeld, MD, PhD, University of Miami

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 2007
  Study Completion Date : June 2007